Howard Kynaston

Medicine · Health Sciences

44h-index11.5kcitations191works17.92yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(74), Prostate Cancer Diagnosis and Treatment(55), Bladder and Urothelial Cancer Treatments(35), Urinary and Genital Oncology Studies(21), Urological Disorders and Treatments(18)

Publications181 total

supplementary materials 1 from Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate Cancer
2025Open Access
Figure S2 from Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate Cancer
2025Open Access
Data from Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate Cancer
2025Open Access
Figure S3 from Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate Cancer
2025Open Access
Figure S1 from Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate Cancer
2025Open Access
Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate Cancer
Clinical Cancer Research·2025Open Access
Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT00541047)
European Urology·2024· 27 citedOpen Access
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial
The Lancet·2024· 45 citedOpen Access
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial
The Lancet·2024· 67 citedOpen Access
Development and Characterisation of a New Patient-Derived Xenograft Model of AR-Negative Metastatic Castration-Resistant Prostate Cancer
Cells·2024· 1 citedOpen Access
Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047)
Annals of Oncology·2024· 45 citedOpen Access
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial
British Journal of Cancer·2023· 30 citedOpen Access
Abstract B061: Updated analysis of “CANCAP03” – A study into the pharmacodynamic biomarker effects of olaparib (PARP inhibitor) ± degarelix (GnRH antagonist) given prior to radical prostatectomy
Cancer Research·2023· 1 cited
Salvage Radiation Therapy After Radical Prostatectomy: Analysis of Toxicity by Dose-Fractionation in the RADICALS-RT Trial
International Journal of Radiation Oncology*Biology*Physics·2023· 26 citedOpen Access
Perception of urinary biomarker tests among patients referred with suspected urological malignancy
BJUI Compass·2023· 3 citedOpen Access
Healthcare systems data in the context of clinical trials – A comparison of cardiovascular data from a clinical trial dataset with routinely collected data
Contemporary Clinical Trials·2023· 5 citedOpen Access
Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
New England Journal of Medicine·2023· 666 citedOpen Access
Patient-Reported Outcomes 12 Years after Localized Prostate Cancer Treatment
NEJM Evidence·2023· 87 citedOpen Access
Safety of maintaining elective and emergency surgery during the COVID-19 pandemic with the introduction of a Protected Elective Surgical Unit (PESU): A cross-specialty evaluation of 30-day outcomes in 9,925 patients undergoing surgery in a University Health Board
Surgery Open Science·2022· 3 citedOpen Access
RADICALS-HD: Reflections before the Results are Known
Clinical Oncology·2022· 9 cited
page 1 of 10Next →

Frequent Co-authors

Malcolm D. Mason(16), Roger Kockelbergh(13), Mahesh Parmar(11), Freddie C. Hamdy(9), Jenny Donovan(9), J. Athene Lane(9), Prasad Bollina(9), James W.F. Catto(9), Alan Doherty(9), David Gillatt(9), Alan Paul(9), Derek J. Rosario(9), Edward Rowe(9), David E. Neal(9), Wen G. Jiang(9), Noel W. Clarke(9), Chris Metcalfe(8), T. J. Peters(8), Michael Davis(7), Emma L. Turner(7)